Implantable Cardioverter-Defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy

International Journal of Cardiology

Volumn 150, Issue 1, 2011, Pages 94-95

  Cardinalli Neto, Augusto ^a   Nakazone, Marcelo A ^a   Grassi, Luciano V ^a   Tavares, Bruno G ^a   Bestetti, Reinaldo B ^a  

^a HOSPITAL DE BASE   (Brazil)

Author keywords

American Trypanosomiasis; Cardiomyopathy; Chagas disease; Heart failure; Implantable Cardioverter Defibrillator; Sudden cardiac death

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; CARDIOGENIC SHOCK; CHAGAS DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SUDDEN DEATH; SURVIVAL RATE; SYSTOLIC HEART FAILURE;

EID: 79960053692     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.03.036     Document Type: Article

References (12)

1. R.B. Bestetti, and A. Cardinalli-Neto Sudden cardiac death in Chagas' heart disease in the contemporary era Int J Cardiol 131 2008 9 17
2. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities Heart Rhythm 5 2008 e1 e62
3. A. Verma, B. Sarak, and A.J. Kaplan Predictors of appropriate Implantable Cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy Pacing Clin Electrophysiol 33 2010 320 329
4. A. Cardinalli-Neto, R.B. Bestetti, J.A. Cordeiro, and V.C. Rodrigues Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving Implantable Cardioverter defibrillator therapy J Cardiovasc Electrophysiol 18 2007 1236 1240 (Pubitemid 350115777)
5. A. Cardinalli-Neto, O.T. Greco, and R.B. Bestetti Automatic Implantable Cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias Pacing Clin Electrophysiol 29 2006 467 470
6. M. Martinelli Filho, S.F. De Siqueira, and H. Moreira Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease Pacing Clin Electrophysiol 23 2000 1944 1946
7. C.J. Borleffs, G.H. van Welsenes, and R.J. van Bommel Mortality risk score in primary prevention Implantable Cardioverter Defibrillator recipients with non-ischemic or ischemic heart disease Eur Heart J 31 2010 712 718
8. M.A. Rossi, S.G. Ramos, and R.B. Bestetti Chagas' heart disease: clinical-pathological correlation Front Biosci 8 2003 e94 e109
9. R.B. Bestetti, J. Coutinho-Netto, L. Staibano, L.Z. Pinto, G. Muccillo, and J.S.M. Oliveira Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease Cardiology 86 1995 202 206
10. R. Rabinovich, C. Muratore, and R. Iglesias Time to first shock in Implantable Cardioverter Defibrillator (ICD) patients with Chagas cardiomyopathy Pacing Clin Electrophysiol 22 1999 202 205 (Pubitemid 29066560)
11. R.B. Bestetti, T.A. Theodoropoulos, and A. Cardinalli-Neto Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy Am Heart J 156 2008 422 430
12. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2